Literature DB >> 6982625

IgE anti-IgG antibodies in patients with juvenile and adult rheumatoid arthritis including Felty's syndrome.

H Permin, E M Egeskjold.   

Abstract

Anti-IgG antibodies (anti-IgG) of the IgE class were studied in sera from patients with juvenile rheumatoid arthritis (JRA), rheumatoid arthritis (RA) and patients with Felty's syndrome (FS) by use of an indirect immunofluorescence technique. Forty-two per cent of 26 patients with JRA had IgE anti-IgG in serum all in low titers. Positive reactions prevailed in patients with multiple joint involvement. Sixty-three per cent of 30 patients with RA and 80% of 20 patients with FS had IgE anti-IgG, the titers found in FS patients being significantly higher. In JRA and FS patients the IgE anti-IgG titers were correlated to the titers of anti-IgG of the IgG class, and for FS patients also with the IgM and IgA classes of anti-IgG. In six of 10 patients with RA the synovial fluid samples from both knees contained IgE anti-IgG. In four of these patients the titers of IgE anti-IgG were higher than in the corresponding serum sample, pointing to a local production. After G-200 Sephadex chromatography IgE anti-IgG were demonstrated in the void volume indicating the presence of these autoantibodies in immune complexes. IgE anti-IgG may be involved in the pathogenesis of JRA and RA by eliciting Type I and III reactions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982625     DOI: 10.1111/j.1398-9995.1982.tb02321.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  6 in total

Review 1.  Clinical significance of anti-IgE autoantibodies and immune complexes containing IgE.

Authors:  C G Magnusson; S G Johansson
Journal:  Clin Rev Allergy       Date:  1989

2.  Autoantibodies as diagnostic tool in juvenile connective tissue diseases.

Authors:  E M Egeskjold
Journal:  Indian J Pediatr       Date:  1989 May-Jun       Impact factor: 1.967

3.  IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes.

Authors:  K Merétey; A Falus; U Böhm; H Permin; A Wiik
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

4.  Mast cells as a target in the treatment of rheumatoid arthritis.

Authors:  O Bakharevski; P F Ryan
Journal:  Inflammopharmacology       Date:  1999       Impact factor: 4.473

5.  IgE rheumatoid factors: quantification in synovial fluid and ability to induce synovial mast cell histamine release.

Authors:  B Gruber; D Ballan; P D Gorevic
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

6.  Phenotypic variability in a child with Felty's syndrome: a case report.

Authors:  Guo-Min Li; Hai-Mei Liu; Wan-Zhen Guan; Yi-Fan Li; Hong Xu; Li Sun
Journal:  BMC Pediatr       Date:  2020-04-07       Impact factor: 2.125

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.